PHARMACEUTICAL COMBINATION OF ETHINYLESTRADIOL AND DROSPIRENONE FOR USE AS A CONTRACEPTIVE

摘要

A Pharmaceutical composition comprising, as a First Active Agent, 6beta, pharmacy, 15beta, 16beta - dimetilen - 3 - oxo - pregn 17alfa - - 4 - - 21- carbolactona (17 cases) in an amount corresponding to a Daily Dose to be administered with lacompo sicyon, from approximately 2mg approximately 4 mgAnd as a Second ACTIVE AGENT, 17alfa - ethinyl estradiol (estradiol) in an amount corresponding to a daily dose of from about 0.01 mgaproximadamente 0.05 mg,Jointly with one or more pharmaceutically acceptable carriers or excipients.In a specific implementation, a number of composicionconsiste Daily dosage units placed in a Packaging Unit, yseparables individually packaged separately,Yproporcionadas for oral Administration for a period of at least 21 consecutive days of daily dosing units, including the combining of drospirenone and ethinyl estradiol.The composition also puedecomprender 7 or less Daily dosage units containing no assets or agents that contain ethinyl estradiol.